Akers Bio logo
Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
November 04, 2015 07:00 ET | Akers Biosciences Inc.
THOROFARE, N.J., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Amaranth Medical
Amaranth Medical Completes MEND-II and RENASCENT Studies and Initiates Study of 120-Micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
October 15, 2015 08:00 ET | Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that enrollment has successfully concluded in its multi-center, international...
SHAPE Logo
SHAPE Task Force Reflects on 10 Years of Progress Toward Heart Attack Eradication
August 17, 2015 07:00 ET | SHAPE
LOS ANGELES, Aug. 17, 2015 (GLOBE NEWSWIRE) -- SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the...
iNeedMD logo
Eagle International Limited Makes $1.5 Million Commitment to Distribute iNeedMD's EKG Glove System
June 23, 2015 06:00 ET | iNeedMD Holdings, Inc.
NEW YORK, June 23, 2015 (GLOBE NEWSWIRE) -- iNeedMD Holdings, Inc. (OTC:NEMD) ("iNeedMD" or the "Company") a medical diagnostic device development company, is proud to announce the signing of an...
iNeedMD logo
iNeedMD Signs Agreement With Turkish Distributor
June 09, 2015 12:44 ET | iNeedMD Holdings, Inc.
NEW YORK, June 9, 2015 (GLOBE NEWSWIRE) -- iNeedMD Holdings, Inc. (OTC:NEMD) ("iNeedMD") a medical device development company, is proud to announce the signing of a distribution agreement with Mayar...
Amaranth Medical
Amaranth Medical Reports Findings from Two FORTITUDE Bioresorbable Scaffold Studies at EuroPCR 2015
May 18, 2015 15:12 ET | Amaranth Medical, Inc.
Mountain View, CA, May 18, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced plans to report clinical results from the Company's ongoing trial of...
Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day
September 24, 2014 09:00 ET | Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to...
Spectranetics Receives CE Mark for TightRail(TM) Rotating Dilator Sheath Platform
May 22, 2014 16:57 ET | The Spectranetics Corporation
COLORADO SPRINGS, Colo., May 22, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced receipt of CE marking for the TightRail™ Rotating Dilator Sheath platform....
Aegerion Pharmaceuticals Initiates Phase 3 Clinical Trial in Japan to Evaluate Lomitapide for Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
April 09, 2014 08:00 ET | Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 9, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of novel therapies for...
Point-of-Care Technologies Will Transform Customer Markets in the Next Decade
March 06, 2014 07:30 ET | Lux Research
BOSTON, MA--(Marketwired - Mar 6, 2014) - Fueled by point-of-care (POC) technologies, the health care industry is headed for transformative change toward a patient-centric model. The near-term...